 Artist: Something Corporate: mp3 download Genre(s): ROck: Alternative Rock Something Corporate's discography:  North Year: 2003 Tracks: 12  Songs For Silent Movies Year: Tracks: 7 Of the myriad georges Jacques Danton True Young alt-rock bands to uprise in the other 2000s, Something Corporate stood out and showed tremendous potential difference drop. On one handwriting, the bandmembers were barely out of high gear wheel school when the prestigious Cali indie punk label Drive-Thru signed them, which helped Something Corporate plug into with a turgid interview of West Coast adolescent hipsters look for a band to claim as their possess. On the other book, though, the band didn't play goon rock; they played refined, literate, radio-ready alt-rock -- a vendible intelligent that MCA recognised just before connecting with the dance orchestra for a debut EP, Audioboxer. Released in tardy 2001, Audioboxer featured only sixer songs yet showcased the band's prognosticate as it synthesized post-grunge alt-rock guitar grind with a bit of torrid emo-styled songwriting and singing. It as well didn't hurt that the dance orchestra boasted a bona fide poster son in Andrew McMahon, a anthesis giving. Before the Orange County, CA, band became Something Corporate, McMahon, drummer Brian Ireland, and bassist Clutch played in some other dance orchestra they had started to contend in a high gear school struggle of the bands. And even though they north Korean won the battle, the isthmus didn't last too long. The turn point came when McMahon met guitarist Josh Partington at a high schooling party. With a renewed sentiency of enthusiasm, the teens started electronic jamming together as Something Corporate. Soon they added guitar player William Tell and were playing local clubs; non shortly after, they were playing one-off gigs opening move for bands like Sugar Ray and Better Than Ezra. Around this time, Drive-Thru came knocking, and even though the label was known primarily as a youth punk rocker label and Something Corporate was far from that, the partnership made sense -- Drive-Thru recognised the band's potential as a crossover move and Something Corporate recognised the label's reputation as a well-thought-of indie. MCA then came into the mental picture in the first place as a distributor, though the major pronounce did role its punch to securities industry the set. Their summer-tinged debut full-length, Going Through the Window, divided up both son and appeared in natural spring 2002. Subsequent touring followed before their slightly darker soph feat, Frederick North, was issued in October 2003. Guitar player William Tell amicably left the grouping in early 2004 to work on on solo corporeal, concisely ahead Something Corporate headed out on a nationwide co-headlining tour of duty with Yellowcard. Bob Anderson (erstwhile of River City High) replaced Tell on the spell; a resilient DVD, Live at the Ventura Theater, was side by side released in November 2004. Aside from playing plenitude of shows, McMahon likewise took time out to exercise on his solo project, Jack's Mannequin. The debut Mannequin record came out in late summertime 2005, just a load-bearing tour was canceled subsequently McMahon was diagnosed with intense lymphoblastic leukemia in June. Touring for both bands was then pose on prevail piece he went through treatment; by the year's end, he had recovered from a successful bone bone marrow transplant from his sister. McMahon then turned his attention to the Jack's Mannequin propose, touring in support of their debut record album, Everything in Transit, which had humiliated into the Billboard Top 40. |
Sunday 7 September 2008
Mp3 music: Something Corporate
Thursday 28 August 2008
NovaRx Initiates Pivotal Phase III Clinical Trial In Lung Cancer Patients
�NovaRx Corporation announced
that the companionship initiated its pivotal Phase III clinical trial of
Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell
lung cancer (NSCLC). The first patient enrolled in the study was treated by
Dr. Lyudmila Bazhenova the trial's principal investigator at the University
of California, San Diego School of Medicine.
The study is designated as the STOP trial because of its expected
endpoints: Survival; Tumor-free, Overall; and Progression-free. It is an
international, multicenter, randomized, double blind study involving up to
700 individuals with advanced stage NSCLC, and testament be conducted at
or so 90 clinical sites in the U.S., Canada, India, and Europe.
In a Phase II clinical visitation, two-year survival among patients with
stages IIIB and IV disease who received Lucanix(R) was significantly thirster
than that of individuals being tempered with the current standard of care. A
second, investigator-initiated stage II study supported these results.
In contrast to conventional crab therapies, where systemic
chemotherapeutic drugs nonspecifically kill normal cells as well as tumor
cells, the therapeutical vaccine developed by NovaRx induces the patient's
immune system to specifically target the genus Cancer. In phase II clinical
studies to date, the side effects of this treatment have included rubor
or tenderness at the injection situation.
"In aesculapian research, you see something like this once in a lifetime,"
said John Nemunaitis, M.D., executive theatre director at the Mary Crowley Medical
Research Center in Dallas, TX and principal investigator of both the Phase
II Lucanix(R) written report and the investigator-initiated Phase II trial.
"This is a very promising plan of attack to crab treatment, and results
reported so far are beyond anyone's expectations. I am very excited to be a
part of this confirmatory exploit, and to be able to proffer this unique
treatment option to my patients," said Dr. Lyudmila Bazhenova, principal
investigator of the STOP trial at the Rebecca and John Moore's Cancer
Center of UCSD. "Traditional chemotherapy for stage IV NSCLC noneffervescent yields
unsatisfying results, and my leslie Townes Hope is that this trial will improve the
natural history of the disease." The FDA granted NovaRx Fast-Track approval
for the Lucanix(R) tryout in March of 2007, and Special Protocol Assessment
approval in January of 2008.
According to the American Cancer Society, in 2008 there will be an
estimated 215,000 new cases of lung cancer diagnosed, and 162,000 deaths
caused by this disease in the United States alone. Lung cancer is the
identification number one grounds of cancer death throughout the world. "The statistics for
orbicular lung cancer deaths are staggering. I am positive that this Phase
III trial testament establish Lucanix(R) as a viable intervention option for
patients with this direful disease," aforementioned Dr. Habib Fakhrai, president and
cofounder of NovaRx.
In Phase II testing, 50 percent of patients entering the trial with
stable disease who standard Lucanix(TM) following one frontline regimen of
chemotherapy lived more than 44 months, compared to less than 10-12 months
for such patients under the current standard of care. In addition, patients
with advanced disease world Health Organization received Lucanix(TM) after zero to five prior
chemotherapy treatments demonstrated a annual survival of 61 pct and
a two-year survival of 41 percent. Such late-stage patients typically
exhibit one-year survival of less than 30 percent. Lucanix(TM) was
shown to acquire only insignificant side effects.
"In addition to significantly increased survival," Fakhrai continued,
"we saw virtually no side personal effects in the patients treated in phase angle II
trials. Based on our previous trial results, we think Lucanix(R) may lead
to a significant advancement in patient charge. We appear forward to continuing
to enroll patients in this very important clinical study."
"We are delighted to have been selected as one of the major centers to
test this highly bright immunotherapeutic approach path to treating
individuals with NSCLC," aforementioned Dr. Julian Molina, star investigator of
the STOP Trial at Mayo Clinic in Rochester, Minnesota.
Lucanix(R) consists of four non-small cell lung cancer cellular phone lines that
have been genetically engineered to close off their immune suppressive
properties. These cell lines are then modified to block a molecule called
transforming growth factor-beta (TGF-beta), which is commonly produced by
cancer cells as a cloak against the body's natural immune system. When
TGF-beta is blocked, the immune system tin mount an anti-tumor response.
The results of Phase II examination were published in the October 10, 2006
edition of the Journal of Clinical Oncology.
Studies to test the therapeutic vaccinum in other types of cancer ar
also in progress. "NovaRx remains committed to developing whole cellbased
therapeutic vaccines for whatsoever form of cancer in which this approach may
significantly meliorate patient outcomes by either curing their disease
entirely, or by stabilizing it over the course of their lives," said Justin
Murdock, CEO and chairman of the board of NovaRx.
Founded in 1997, NovaRx Corp. is a clinical-stage biopharmaceutical
company dedicated to the discovery, development, and commercialization of
novel cell-based therapeutic vaccines for the treatment of cancer. The
company's 24,000 square foot headquarters in San Diego, CA, house corporate
offices and manufacture operations. The proprietary core technology upon
which Lucanix(R) is based has been exclusively accredited to NovaRx on a
worldwide base. Lucanix(R) is a trademark of NovaRx Corp.
For more information on the NovaRx Lucanix(R) Phase III STOP Trial in
NSCLC please bring down http://www.NovaRx.com.
NovaRx Corporation
http://www.NovaRx.com
More info
that the companionship initiated its pivotal Phase III clinical trial of
Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell
lung cancer (NSCLC). The first patient enrolled in the study was treated by
Dr. Lyudmila Bazhenova the trial's principal investigator at the University
of California, San Diego School of Medicine.
The study is designated as the STOP trial because of its expected
endpoints: Survival; Tumor-free, Overall; and Progression-free. It is an
international, multicenter, randomized, double blind study involving up to
700 individuals with advanced stage NSCLC, and testament be conducted at
or so 90 clinical sites in the U.S., Canada, India, and Europe.
In a Phase II clinical visitation, two-year survival among patients with
stages IIIB and IV disease who received Lucanix(R) was significantly thirster
than that of individuals being tempered with the current standard of care. A
second, investigator-initiated stage II study supported these results.
In contrast to conventional crab therapies, where systemic
chemotherapeutic drugs nonspecifically kill normal cells as well as tumor
cells, the therapeutical vaccine developed by NovaRx induces the patient's
immune system to specifically target the genus Cancer. In phase II clinical
studies to date, the side effects of this treatment have included rubor
or tenderness at the injection situation.
"In aesculapian research, you see something like this once in a lifetime,"
said John Nemunaitis, M.D., executive theatre director at the Mary Crowley Medical
Research Center in Dallas, TX and principal investigator of both the Phase
II Lucanix(R) written report and the investigator-initiated Phase II trial.
"This is a very promising plan of attack to crab treatment, and results
reported so far are beyond anyone's expectations. I am very excited to be a
part of this confirmatory exploit, and to be able to proffer this unique
treatment option to my patients," said Dr. Lyudmila Bazhenova, principal
investigator of the STOP trial at the Rebecca and John Moore's Cancer
Center of UCSD. "Traditional chemotherapy for stage IV NSCLC noneffervescent yields
unsatisfying results, and my leslie Townes Hope is that this trial will improve the
natural history of the disease." The FDA granted NovaRx Fast-Track approval
for the Lucanix(R) tryout in March of 2007, and Special Protocol Assessment
approval in January of 2008.
According to the American Cancer Society, in 2008 there will be an
estimated 215,000 new cases of lung cancer diagnosed, and 162,000 deaths
caused by this disease in the United States alone. Lung cancer is the
identification number one grounds of cancer death throughout the world. "The statistics for
orbicular lung cancer deaths are staggering. I am positive that this Phase
III trial testament establish Lucanix(R) as a viable intervention option for
patients with this direful disease," aforementioned Dr. Habib Fakhrai, president and
cofounder of NovaRx.
In Phase II testing, 50 percent of patients entering the trial with
stable disease who standard Lucanix(TM) following one frontline regimen of
chemotherapy lived more than 44 months, compared to less than 10-12 months
for such patients under the current standard of care. In addition, patients
with advanced disease world Health Organization received Lucanix(TM) after zero to five prior
chemotherapy treatments demonstrated a annual survival of 61 pct and
a two-year survival of 41 percent. Such late-stage patients typically
exhibit one-year survival of less than 30 percent. Lucanix(TM) was
shown to acquire only insignificant side effects.
"In addition to significantly increased survival," Fakhrai continued,
"we saw virtually no side personal effects in the patients treated in phase angle II
trials. Based on our previous trial results, we think Lucanix(R) may lead
to a significant advancement in patient charge. We appear forward to continuing
to enroll patients in this very important clinical study."
"We are delighted to have been selected as one of the major centers to
test this highly bright immunotherapeutic approach path to treating
individuals with NSCLC," aforementioned Dr. Julian Molina, star investigator of
the STOP Trial at Mayo Clinic in Rochester, Minnesota.
Lucanix(R) consists of four non-small cell lung cancer cellular phone lines that
have been genetically engineered to close off their immune suppressive
properties. These cell lines are then modified to block a molecule called
transforming growth factor-beta (TGF-beta), which is commonly produced by
cancer cells as a cloak against the body's natural immune system. When
TGF-beta is blocked, the immune system tin mount an anti-tumor response.
The results of Phase II examination were published in the October 10, 2006
edition of the Journal of Clinical Oncology.
Studies to test the therapeutic vaccinum in other types of cancer ar
also in progress. "NovaRx remains committed to developing whole cellbased
therapeutic vaccines for whatsoever form of cancer in which this approach may
significantly meliorate patient outcomes by either curing their disease
entirely, or by stabilizing it over the course of their lives," said Justin
Murdock, CEO and chairman of the board of NovaRx.
Founded in 1997, NovaRx Corp. is a clinical-stage biopharmaceutical
company dedicated to the discovery, development, and commercialization of
novel cell-based therapeutic vaccines for the treatment of cancer. The
company's 24,000 square foot headquarters in San Diego, CA, house corporate
offices and manufacture operations. The proprietary core technology upon
which Lucanix(R) is based has been exclusively accredited to NovaRx on a
worldwide base. Lucanix(R) is a trademark of NovaRx Corp.
For more information on the NovaRx Lucanix(R) Phase III STOP Trial in
NSCLC please bring down http://www.NovaRx.com.
NovaRx Corporation
http://www.NovaRx.com
More info
Friday 8 August 2008
Mya Blames Cash Issues For Missed Show
R+B vocalizer MYA has slammed reports her "diva behaviour" caused the cancellation of a recent cabaret gig in Barbados, blaming non-payment for the scrapped show.
The Case of the Ex star was scheduled to host and perform at the Celebrity Party event at Club NXS earlier this month (Jul08).
However, she pulled out days before the gig after learning the event promoter had a lack of funds, and was thus unable to pay her for the appearance.
Mya was heavily criticised by partygoers for the late cancellation - but she insists it wasn't her fault, and has apologised to her fans for the incident.
In a statement released on behalf of the star, her attorney Paul Gardner says, "A workweek and a half prior to the scheduled appearing at Club NXS in St. Lawrence Gap, Mya was informed that the promoter of this event did non have the funds available to oblige her appearance.
"Despite this, the promoters of the 'Celebrity Party' went on to include Mya on the promotional material, and to announce her appearance on the local radiocommunication station. Because of the lack of funding, Mya was no longer obligated to appear at this event.
"Furthermore, in addition to a last second meet and greet with young students and athletes, Mya attended a dinner organised by the local radio station. Unbeknownst to her the radio station had advertised her presence as the prize for two contest winners. Mya graciously attended this dinner, even though this she was not required to do so under the contract.
"Mya would like to apologise to her fans for the confusion and letdown caused by this position. However, she would also like her fans to know that she takes her professional engagements selfsame seriously, and would have attended this event had it been organised right and if the promoter had the originally in agreement upon pecuniary compensation available."
More information
Tuesday 1 July 2008
Girl Talk maps fall tour dates
Girl Talk aka Greg Gillis has announced a string of dates across the US and Canada this fall, kicking off October 9 in Philadelphia.
The dates follow a string of summer shows from Gillis, including slots at the Capitol Hill Block Party in Seattle on July 25, Lollapalooza in Chicago on August 3, and All Points West in New Jersey on August 8 as well as a handful of solo shows.
The tour will run through November 14 when it wraps up in Foxborough, MA.
The dates are:
Boulder, CO Fox Theatre (July 11)
Aspen, CO Belly Up (12)
Victoria, British Columbia �?? Sugar (23)
Vancouver, British Columbia Commodore Ballroom (24)
Seattle, WA Capitol Hill Block Party (25)
Portland, OR Roseland Theater (26)
Chicago, IL Grant Park Lollapalooza (August 3)
Jersey City, NJ Liberty State Park All Points West Festival (8)
Philadelphia, PA Starlight Ballroom (October 9)
Washington, DC 9:30 Club (10)
Baltimore, MD Sonar (11)
Carrboro, NC Cat's Cradle (13)
Asheville, NC Orange Peel (14)
Knoxville, TN Valarium (15)
Atlanta, GA Variety Playhouse (16)
New Orleans, LA House of Blues (17)
Houston, TX Warehouse Live! (18)
Austin, TX Emo's (20)
Dallas, TX Palladium Ballroom (21)
Tucson, AZ Rialto Theater (23)
Los Angeles, CA Henry Fonda Theater (24, 25)
San Francisco, CA The Fillmore (27, 28)
Salt Lake City, UT In the Venue (30)
Denver, CO Odgen Theater (31)
Lawrence, KS The Granada Theatre (November 1)
Minneapolis, MN First Avenue (3)
Milwaukee, WI Turner Hall Ballroom (4)
Urbana, IL Canopy Club (5)
Nashville, TN Cannery Ballroom (6)
Louisville, KY Headliners Music Hall (7)
Cincinnati, OH Bogart's (9)
Cleveland, OH Beachland Ballroom (10)
Pontiac, MI Eagle Theatre (11)
Toronto, Ontario Koolhaus (12)
Montreal, Quebec Club Soda (13)
Foxborough, MA Showcase Live (14)
--By our New York staff.
Find out more about NME.
The dates follow a string of summer shows from Gillis, including slots at the Capitol Hill Block Party in Seattle on July 25, Lollapalooza in Chicago on August 3, and All Points West in New Jersey on August 8 as well as a handful of solo shows.
The tour will run through November 14 when it wraps up in Foxborough, MA.
The dates are:
Boulder, CO Fox Theatre (July 11)
Aspen, CO Belly Up (12)
Victoria, British Columbia �?? Sugar (23)
Vancouver, British Columbia Commodore Ballroom (24)
Seattle, WA Capitol Hill Block Party (25)
Portland, OR Roseland Theater (26)
Chicago, IL Grant Park Lollapalooza (August 3)
Jersey City, NJ Liberty State Park All Points West Festival (8)
Philadelphia, PA Starlight Ballroom (October 9)
Washington, DC 9:30 Club (10)
Baltimore, MD Sonar (11)
Carrboro, NC Cat's Cradle (13)
Asheville, NC Orange Peel (14)
Knoxville, TN Valarium (15)
Atlanta, GA Variety Playhouse (16)
New Orleans, LA House of Blues (17)
Houston, TX Warehouse Live! (18)
Austin, TX Emo's (20)
Dallas, TX Palladium Ballroom (21)
Tucson, AZ Rialto Theater (23)
Los Angeles, CA Henry Fonda Theater (24, 25)
San Francisco, CA The Fillmore (27, 28)
Salt Lake City, UT In the Venue (30)
Denver, CO Odgen Theater (31)
Lawrence, KS The Granada Theatre (November 1)
Minneapolis, MN First Avenue (3)
Milwaukee, WI Turner Hall Ballroom (4)
Urbana, IL Canopy Club (5)
Nashville, TN Cannery Ballroom (6)
Louisville, KY Headliners Music Hall (7)
Cincinnati, OH Bogart's (9)
Cleveland, OH Beachland Ballroom (10)
Pontiac, MI Eagle Theatre (11)
Toronto, Ontario Koolhaus (12)
Montreal, Quebec Club Soda (13)
Foxborough, MA Showcase Live (14)
--By our New York staff.
Find out more about NME.
Sunday 22 June 2008
Los Planetas
Artist: Los Planetas
Genre(s):
Other
Discography:
Contra La Ley De La Gravedad
Year: 2004
Tracks: 12
Spanish alternative group los Planetas was formed in the other '90s, fashioning their debut EP, called Medusoid, in 1993. Led by J. Penh and guitarist Florent, the band's first gear album was released in 1994 by RCA. It was called Super 8. In January of 1998, los Planetas moved to New York to record Una Semana en el Motor De Un Autobús, followed by 2000's Unidad De Desplazamiento.
'Juno' Star: 'I Feel Weird Being Nominated'
Sunday 15 June 2008
Britney 'hot' in Pussycat Dolls cameo
Britney Spears looks "hot and blonde" in her cameo appearance in the Pussycat Dolls' new video.
The troubled singer - who has been working hard to get back on track following her alleged breakdown earlier this year - shot her scenes for the girl group’s latest track When I Grow Up in California.
A set source said: "It was carefully planned out.
"In the scene shot, Britney is driving in a car. They all wave at each other as they are passing in traffic - that is it. It is genius and you will love it! Of course, Britney looks hot and blonde."
The Pussycat Dolls filmed the part of the scene in a blue convertible Chevy Imapla.
The insider added: "They are singing and in traffic - looking hot.
"It is a very short sequence, but Britney had a lot of fun with it. Britney really likes the Dolls' music and when she saw them on the MTV Movie Awards at the weekend, she was totally down to do the video."
This is not the first time mother-of-two Britney has teamed up with the group.
She once appeared with the Pussycat Dolls as part of a special performance for her older brother Bryan’s birthday.
See Also
Wednesday 4 June 2008
Billy Bob Thornton on Angelina Jolie pregnancy: “I�m just so happy for her”
Angelina Jolie’s ex-husband Billy Bob Thornton is full of praise for his former wife.
“I think she was always meant to be a mother in so many ways,” Billy Bob tells Extra. “I�m just so happy for her.”
Jolie married Thornton, whom she had met on the set of Pushing Tin, in May 5, 2000. They split in 2002 shortly after she adopted Maddox, now 6, from Cambodia. Their divorce was finalized a year later, and although the actor was listed as Maddox�s father, Angelina received sole custody, and Brad Pitt officially adopted Maddox in 2006.
See Also
Thursday 29 May 2008
Baden Powell
Artist: Baden Powell
Genre(s):
Jazz
Other
Discography:
Os Afro Sambas
Year: 2000
Tracks: 11
The Best of
Year:
Tracks: 14
Baden Powell is a Brazilian instrumentalist with a solid international reputation. A gifted musician and composer, he bridges the gap 'tween classical art and democratic warmth and was a winder fig in the bossa nova movement.
Born in the Varre e Sai dominion, he was baptized after his granddaddy, a musician and conductor himself, whose forefather was an admirer of the Boy Scouts cave in. When he was quaternity months previous, his family line stirred to the james Jerome Hill of São Cristóvão in the metropolis of Rio. His father, the violonista Lino de Aquino, promoted regular get-togethers (rodas) of chorões at his home plate, at which renowned name calling of Rio's music used to play, such as Pixinguinha, his brother China, the sambista Donga, and so many others. At 8, his don took him to Rádio Nacional where Powell met Meira (Jaime Florence), a famous violonista at the prison term a member of Benedicto Lacerda's regional. Powell would study violão with him for five years. Through Meira, a broad-minded musician, he discovered classics such as Segovia and Tarrega, along with Brazilian edgar Lee Masters such as Garoto and Dilermando Reis. At 9, he presented himself at Renato Murce's show Papel Carbono on Rádio Nacional, winning first base place as a guitar soloist. At 13, he used to ply from schooltime, earning his low gear cachets at the neighbourhood parties. After finish high schooltime, he joined the cast of Rádio Nacional as an accompanyist. In that time, he traveled through Brazil with the radio's singers. In 1955, he united Ed Lincoln's trio, playing jazz at the Plaza nightspot. The place was a focal gunpoint for musicians, journalists, and aficionados concerned in nothingness. It should be regarded as the second space where bossa nova was organism generated (the first being Cantina do César, later Johnny Alf's number one appearances), adverse to the unwashed notion of bossa being innate at Zona Sul (S side's) apartments.
At that prison term, Powell began to compose "Deve Ser Amor," "Encontro Com a Saudade," "Não é Bem Assim," and his number one bountiful strike, 1956's "Samba Triste," with lyrics by Billy Blanco and which would be recorded by Lúcio Alves in 1960. In 1962, he met his next married person, VinÃcius de Moraes, a composer, poet, isaac Bashevis Singer, and diplomat. Their number one birdcall was "Canção de Ninar Meu Bem," a great achiever from the commencement. Following that, they came up with "Samba em Prelúdio" (recorded still in 1962 by Geraldo Vandré/Ana Lúcia), "Consolação" (recorded by Nara Leão), "Samba da Bênção," "Tem Dó," "Só por Amor," "Bom Dia, Amigo," "Labareda," and "Samba do Astronauta" (recorded by Powell in 1964). At this point, Powell was already a far-famed musician and composer, with good connections on the artistic panorama and wide exposure in the media. In that year, he accompanied SÃlvia Telles at her illustrious prove at the Jirau club. In 1963, he recorded his number 1 LP, Um Violão na Madrugada (Philips). In that year, he traveled to Paris where he presented himself at the Olympia theater with great success, victimization a repertory of classical music and his possess compositions. He likewise played regularly in a season at the Bilboquet club and composed the soundtrack to the motion picture Le Grabuje. In 1964, he returned to Brazil and recorded the LP À Vontade, which included a report by Tom Jobim and VinÃcius, "Samba do Avião." He likewise wrote, in that year, the samba "Berimbau" with lyrics by VinÃcius. Other duo's compositions that year were "Além do Amor," "Valsa sem Nome," "Deve ser Amor," "Canção do Amor Ausente," "Consolação," "Deixa," "Amei Tanto," "Tempo Feliz," and "Samba da Bênção." The latter was included in Claude Lelouch's pic Un Homme et une Femme, under the form of address "Samba Saravah."
Travelling to Bahia, Powell stayed on that point for six-spot months and researched the Afro traditions developed on Brazilian soil, specially the musical tradition emanating from the ancient sorcery rituals of candomblé and umbanda. The side by side phase of his compositional association with VinÃcius would be called by Powell as the Afro-sambas, mirroring the findings of that menstruum: 1965's "Tristeza e Solidão" and "Bocoché" and 1966's "Canto do Xangô" and "Canto de Ossanha," the latter recorded by Elis Regina in 1966 with great success. Taking Bahia folklore, Powell added his Carioca touch, delivery the Afro custom a more Brazilian notion. In 1999, Powell, of late reborn, regretted and deplored the Afro-samba phase as "devil's music" in a controverted and disappointing interview.
In 1965, underlying isaac M. Singer Elizeth Cardoso presented Powell/VinÃcius' "Valsa do Amor que Não Vem" at the number 1 Festival of Brazilian Popular Music (TV Excelsior), São Paulo, winning second place. The side by side year, AluÃsio de Oliveira produced another album by Powell, this time for his possess landmark label Elenco, that deeply engaged in the use of the charles Herbert Best musicians, going the commercial side in the background; alas, it caused the splendid label's death some geezerhood later. Taking advantage of the Brazilian go of Caterina Valente, world Health Organization was organism accompanied by drummer Jimmy Pratt, de Oliveira took him and recorded Baden Powell Swings With Jimmy Pratt. Also in that year, TV Excelsior promoted the National Festival of Popular Music, at which tiro Milton Nascimento north Korean won quarter place with "Cidade Vazia" (Powell/Lula Freire) and Powell with VinÃcius recorded their Afro-sambas "Canto de Xangô," "Canto de Iemanjá," and "Canto de Ossanha" for Forma, along with "Berimbau" and "Samba da Bênção." He likewise took a season with Elis Regina at Rio's club Zum-Zum. The LPs O Mundo Musical de Baden Powell (Barclay/RGE), recorded in France; Baden Powell ao Vivo no Teatro Santa Rosa (Elenco); and Tempo Feliz
(Forma/Philips) were all recorded in 1966. In that period, he played in the U.S. with Stan Getz. In 1967, he recorded in Paris, France, the album O Mundo Musical No. 2, accompanied by the Paris Symphonic Orchestra. In that yr, his O Mundo Musical de Baden Powell was awarded with the Golden Record in Paris and he presented himself at the Jazz Festival in Berlin, Germany, with American jazz guitarists Jim Hall and Barney Kessel. In 1968, a novitiate Paulo César Pinheiro (now a illustrious obeche composer) composed with Powell the obeche "Lapinha," which was presented by Elis Regina at the TV Record's beginning Samba Biennial, victorious first place. The span would likewise compose, among others, "Cancioneiro," "Samba do Perdão," "Meu Réquiem," "É de Lei," "Refém da Solidão," "Aviso aos Navegantes," and "Carta de Poeta." Also from 1968 is the LP Baden Powell (Elenco) with the noted "Manhã de Carnaval" or "Funfair," by LuÃs Bonfá and Antônio Maria, and the show O Mundo Musical de Baden Powell. In 1969, he recorded Vinte e Sete Horas de Estúdio (Elenco). Next yr in Paris, he recorded for Barklay the three-album box sic Baden Powell Quartet and the LP Baden Powell, which had Pixinguinha's songs. For Elenco, he recorded the LP Estudos. In 1972, he recorded for Philips the LP É de Lei. Solitude on Guitar was recorded the following yr in Germany and in 1974, he recorded in Paris the live LP Baden Powell (Barklay/RGE), and in 1975 recorded the LP Baden Powell Trio & Ópera de Frankfurt. He then moved to Baden-Baden (Deutschland), staying at that place for little Joe days. In 1994, already living in Brazil once more, he released the record Baden Powell de Rio à Paris. In that same year, he performed together with his sons, Louis Marcel (violão) and Phillipe (forte-piano), at the CecÃlia Meireles Hall in Rio, with the concert recorded and released on a CD, titled Baden Powell & Filhos, through CID. In 1995, his concert at the Montreux Festival was recorded on CD under the title Baden Powell Live in Montreux. Also in that yr, he was awarded with the Prêmio Shell for his complete works. In 1996, he toured in France with Brazilian accordionist Sivuca and recorded the CD Baden Powell Live at the Rio Jazz Club. After disbursal several weeks in the infirmary, Baden Powell died on September 26, 2000, at the historic period of 63.
Wednesday 28 May 2008
Die Happy
Artist: Die Happy
Genre(s):
Pop: Pop-Rock
Alternative
Discography:
Bitter To Better
Year: 2005
Tracks: 11
The Weight Of The Circumstances
Year: 2003
Tracks: 12
Beautiful Morning
Year: 2002
Tracks: 13
Supersonic Speed
Year: 2000
Tracks: 13
Alternative stone quartette Die Happy formed in Ulm, Germany, in 1993. Guitarist Thorsten Mewes, bassist Julian Rosenthal, and drummer Marcus Heinzmann auditioned a series of singers before in conclusion subsiding on Czech-born Marta Jandová. The grouping played its get-go live gig in the natural spring of 1994, at mid-year recording the EP Better Than Nothing. A self-released uncut, Dirty Flowers, followed in early 1996. Drummer Holger Fiesel replaced Heinzmann prior to roger Huntington Sessions for the 1997 EP Promotion. During an appearance at the 1998 Rockstiftung unsigned dance orchestra contest, Die Happy captured the attention of A&R execs from Epic/Sony, only narrow negotiations fell through and Fiesel shortly announced his way out, clearing the means for drummer Jürgen Stiehle. Rosenthal was the next to resign, and later a series of auditions, the leftover triple selected bassist Ralph Rieker. In late 1999, this personification of Die Happy signed to BMG Ariola, and in 2001 issued their major-label debut, Supersonic Speed. Beautiful Morning followed a twelvemonth by and by, and in 2003 Die Happy traveled to Los Angeles to lead off sour with hitmaking producers The Matrix on the band's third RCA endeavour, The Weight of the Circumstances. Virtual unknown Udo Rinklin helmed the 2005 followup, Bitter to Better, although multi-platinum shlockmeister Diane Warren penned the lay "I Am." No Nuts No Glory reached the German Top 30 upon its 2006 dismission.
Rock Pioneer Lou Reed Joins SIRIUS Satellite Radio
Seger Bob and The Silver Bullet Band
Artist: Seger Bob and The Silver Bullet Band
Genre(s):
Rock
Discography:
Greatest Hits
Year: 1994
Tracks: 14
The Distance
Year: 1982
Tracks: 9
Angelina Jolie in plane collapse?
Actress Angelina Jolie has reportedly collapsed while on an 18-hour flight.
According to The Sun, the star, who is reported to be pregnant, began to feel ill on a flight from Iraq and was attended to by airline staff, who gave her oxygen.
A passenger on the flight told the newspaper: "She started to get nosebleeds and cramps. She fainted."
According to The Sun, the star, who is reported to be pregnant, began to feel ill on a flight from Iraq and was attended to by airline staff, who gave her oxygen.
A passenger on the flight told the newspaper: "She started to get nosebleeds and cramps. She fainted."
Farrell replacing Ledger in movie?
It has been reported that Colin Farrell is one of a trio of stars who will replace the late Heath Ledger in his final film 'The Imaginarium of Doctor Parnassus'.
The film website Ain't It Cool News is reporting that Farrell, Johnny Depp and Jude Law will all play the character played by Ledger in scenes not yet shot for the Terry Gilliam-fantasy.
In the film Ledger's character falls through a mirror on four separate occasions and changes his appearance.
'The Imaginarium of Doctor Parnassus' tells the story of a travelling show which offers its audience the opportunity to choose between light and dark.
The film website Ain't It Cool News is reporting that Farrell, Johnny Depp and Jude Law will all play the character played by Ledger in scenes not yet shot for the Terry Gilliam-fantasy.
In the film Ledger's character falls through a mirror on four separate occasions and changes his appearance.
'The Imaginarium of Doctor Parnassus' tells the story of a travelling show which offers its audience the opportunity to choose between light and dark.
Electric Light Orchestra
Artist: Electric Light Orchestra
Genre(s):
Rock
Rock: Pop-Rock
Discography:
Zoom
Year: 2001
Tracks: 13
Live In Bbc (CD2)
Year: 2001
Tracks: 11
Live In Bbc (CD1)
Year: 2001
Tracks: 11
Friends and Relatives CD 2
Year: 1999
Tracks: 13
Friends And Relatives CD 1
Year: 1999
Tracks: 15
Live at Wembley'78
Year: 1988
Tracks: 15
Balance Of Power
Year: 1986
Tracks: 10
Time
Year: 1981
Tracks: 13
Xanadu
Year: 1980
Tracks: 10
Discovery
Year: 1979
Tracks: 9
Eldorado Live in Osaka Japan 1978 (CD2)
Year: 1978
Tracks: 8
Eldorado Live in Osaka Japan 1978 (CD1)
Year: 1978
Tracks: 9
Out Of The Blue
Year: 1977
Tracks: 17
A New World Records
Year: 1976
Tracks: 9
Face The Music
Year: 1975
Tracks: 8
The Night the Lights Went On (In Long Beach)
Year: 1974
Tracks: 7
Eldorado
Year: 1974
Tracks: 12
On The Third Day
Year: 1973
Tracks: 9
No Answer
Year: 1972
Tracks: 9
The Electric Light Orchestra's ambitious thus far resistless fusion of Beatlesque pop, graeco-Roman arrangements, and futurist iconography rocketed the group to massive commercial winner passim the seventies. ELO was formed in Birmingham, England in the fall of 1970 from the ashes of the case art-pop jazz band the Move, reuniting frontman Roy Wood with guitarist/composer Jeff Lynne, bassist Rick Price, and drummer Bev Bevan. Announcing their intentions to "pick up where 'I Am the Walrus' left hand off," the quadruple sought to decorate their winsomely melodic stone with classical flourishes, tapping French horn player Bill Hunt and fiddler Steve Woolam to record their self-titled debut LP (issued as No Answer in the U.S.). In the months betwixt the roger Huntington Sessions for the record album and its eventual release, the Move embarked on their word of farewell term of enlistment, with Woolam exiting the ELO lineup prior to the tour of violinist Wilf Gibson, bassist Richard Tandy, and cellists Andy Craig and Hugh McDowell; disdain the protracted delay, Electric Light Orchestra sold powerfully, buoyed by the success of the U.K. Top Ten hit "10538 Overture."
All the same, Wood shortly left ELO to variant Wizzard, taking Hunt and McDowell with him; Price and Craig were shortly out as advantageously, and with the additions of bassist Michael D'Albuquerque, keyboardist Richard Tandy, and cellists Mike Edwards and Colin Walker, Lynne assumed vocal duties, with his Lennonesque tenor proving the ideal full complement to his more and more advanced melodies. With 1973's ELO II, the mathematical group returned to the Top Ten with their grandiose cover of the Chuck Berry chestnut "Roll Over Beethoven"; the record was as well their commencement American hit, with 1974's El Dorado yielding their first U.S. Top Ten, the lovely "Can't Get It Out of My Head." Despite Electric Light Orchestra's commercial-grade success, the band remained relatively faceless; the batting order changed always, with sole mainstays Lynne and Bevan preferring to allow their elaborate stage shows and omnipresent starship imagery instead dish as the group's world theatrical role. 1975's Face the Music went atomic number 79, generating the hits "Evil Woman" and "Strange Magic," piece the reexamination, A New World Record, sold five-spot meg copies internationally thanks to standouts like "Telephony Line" and "Livin' Thing."
The platinum-selling double-LP, Out of the Blue, appeared in 1977, although the record's success was tempered more or less by a causa filed by Electric Light Orchestra against their former allocator, United Artists, whom the band charged awash the food market with defective copies of the album. Columbia distributed the remainder of the group's output, issued through their own Jet Records imprint, beginning with 1979's Find, which notched the Top Ten entries "Glisten a Little Love" and "Don't Bring Me Down." In the fire up of ELO's best-selling Superlative Hits digest, Lynne wrote several songs for the soundtrack of the Olivia Newton-John photographic film Xanadu, including the hit title track. The succeeding proper Electric Light Orchestra record album, 1981's Time, generated their last Top Ten hit, "Nurse on Tight." Following 1983's Secret Messages, Bevan left hand the group to join Black Sabbath, although he returned to the plica for 1986's Balance of Power, which disdain the presence of the Top 20 hit "Vocation America" received little pursuit from fans and media alike.
However, as Electric Light Orchestra's vocation descended, Lynne emerged as a sought-after producer, helming well-received comebacks from George Harrison (1987's Cloud Nine) and Roy Orbison (1989's Enigma Girl) and to boot re-teaming with both tilt legends as well as Bob Dylan and Tom Petty in the hit supergroup the Traveling Wilburys. Lynne made his solo debut in 1990 with Armchair Theatre merely otherwise fatigued the decade forbidden of the limelight, alternatively producing real for Joe Cocker, Tom Jones, and Paul McCartney in accession to working on the Beatles' Anthology project. In 1988, meanwhile, Bevan formed Electric Light Orchestra Part II with vocalizer Neil Lockwood, keyboardist Eric Troyer, and bassist Pete Haycock; although Lynne filed courting against the group (hence the "Part II" tag), a self-titled LP followed in 1991, with a alive collection recorded with the Moscow Symphony Orchestra appearance a class later. Outside of 1994's Consequence of Truth, subsequent ELO II releases have been alive efforts as well.
David Beckham's Bosses Defend Star Behavior
David Beckham's bosses at Los Angeles soccer team, the L.A. Galaxy, have come to his defense, after supporters of the club have started to blame his celebrity lifestyle for the lack of games the team has won.According to his accusers, Beckham spends too much time off the pitch hanging with the stars and on the red carpet, rather than concentrating on his game. However, a spokesperson for the L.A. Galaxy has defended their key player saying, "He's the first one on the training pitch and the last one off. What he does in his private life in no way reflects on the team. He's a major celebrity and he's bound to attract attention wherever he goes."Beckham moved his family to Los Angeles last year, with much fanfare, after signing a multi-million dollar contract - however, the team have yet to win many games.Photo courtesy of Motorola.
Subscribe to:
Posts (Atom)